GlobeNewswire Inc | Nov 9, 2021 08:00AM EST

November 09, 2021

NESS ZIONA, Israel, Nov. 09, 2021 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE) (BiomX or the Company), a clinical-stage microbiome company advancing novel natural and engineered phage therapies that target specific pathogenic bacteria, today announced that the Company will host a conference call and a live audio webcast on Monday, November 15th, 2021, at 8:00 a.m. EDT, to report third quarter 2021 financial results and provide business updates. To participate in the conference call, please dial 1-877-407-0724 (U.S.), 1-809-406-247 (Israel) or 1-201-389-0898 (International). The live and archived webcast will be available in the Investors section of the Companys website atwww.biomx.com.

About BiomX

BiomX is a clinical-stage microbiome company developing both natural and engineered phage cocktails designed to target and destroy bacteria that affect the appearance of skin, as well as target bacteria in the treatment of chronic diseases, such as inflammatory bowel disease, primary sclerosing cholangitis, cystic fibrosis, atopic dermatitis and colorectal cancer. BiomX discovers and validates proprietary bacterial targets and customizes phage compositions against these targets.

Additional information is available atwww.biomx.com, the content of which does not form a part of this press release.

BiomX, Inc.Anat PrimovichCorporate Project Manager+97250-6977227

Media:LifeSci Advisors, LLCJohn Mullalyjmullaly@lifesciadvisors.com

Source: BiomX Inc